Eosinophilic bronchiectasis increases length and cost of hospitalization: a retrospective analysis in a hospital of southern China from 2012 to 2020 by Chengcheng Lei, Zhimin Zeng, Fengjia Chen, Yubiao Guo, Yangli Liu

Get full text

Adenocarcinomatous-predominant subtype associated with a better prognosis in adenosquamous lung carcinoma by Yangli Liu, Ying Zhu, Lihong Bai, Fengjia Chen, Jue Wang, Yubiao Guo

Get full text

Exploration of induced sputum BIRC3 levels and clinical implications in asthma by Lijuan Du, Changyi Xu, Zhimin Zeng, Fengjia Chen, Kun Tang, Yuxia Liang, Yubiao Guo

Get full text

Association of increased basic salivary proline‐rich protein 1 levels in induced sputum with type 2‐high asthma by Fengjia Chen, Yuxia Liang, Zhimin Zeng, Lijuan Du, Changyi Xu, Yubiao Guo, Canmao Xie

Get full text

Increased expression of CSF1 in patients with eosinophilic asthma by Lijuan Du, Lu Tang, Lisha Xiao, Kun Tang, Zhimin Zeng, Yuxia Liang, Yubiao Guo

Get full text

Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma by Zhimin Zeng, Yuxia Liang, Jia Shi, Lisha Xiao, Lu Tang, Yubiao Guo, Fengjia Chen, Gengpeng Lin

Get full text

Increased expression of IL1-RL1 is associated with type 2 and type 1 immune pathways in asthma by Changyi Xu, Lijuan Du, Fengjia Chen, Kun Tang, Lu Tang, Jia Shi, Lisha Xiao, Zhimin Zeng, Yuxia Liang, Yubiao Guo

Get full text

Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide by Yuying Zeng, Yun Zhang, Xinyan Huang, Lizhen Song, Katherine Polsky, Yifan Wu, Farrah Kheradmand, Yubiao Guo, Linda K. Green, David B. Corry, John M. Knight

Get full text

Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme by Wuping Bao, Yingying Zhang, Jingqing Hang, Yubiao Guo, Wei Tang, Chunmei Yun, Jingmin Deng, Meiling Jin, Kefang Lai, Huapeng Yu, Maarten Beekman, Xin Zhou, Min Zhang

Get full text

Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib‐refractory ALK‐positive NSCLC from a phase II study by Jing Zheng, Tao Wang, Yunpeng Yang, Jie Huang, Jifeng Feng, Wu Zhuang, Jianhua Chen, Jun Zhao, Wei Zhong, Yanqiu Zhao, Yiping Zhang, Yong Song, Yi Hu, Zhuang Yu, Youling Gong, Yuan Chen, Feng Ye, Shucai Zhang, Lejie Cao, Yun Fan, Gang Wu, Yubiao Guo, Chengzhi Zhou, Kewei Ma, Jian Fang, Weineng Feng, Yunpeng Liu, Zhendong Zheng, Gaofeng Li, Huijie Wang, Shundong Cang, Ning Wu, Wei Song, Xiaoqing Liu, Shijun Zhao, Lieming Ding, Giovanni Selvaggi, Yang Wang, Shanshan Xiao, Qian Wang, Zhilin Shen, Jianya Zhou, Jianying Zhou, Li Zhang

Get full text